Background. Previous work suggests that anaesthesia and surgery amplify the pathology and cognitive impairment of animals made vulnerable via age or specific transgenes. We hypothesized that surgery under propofol anaesthesia, a widely used i.v. general anaesthetic, has minimal delayed cognitive and neuroinflammatory sequelae in a vulnerable mouse transgenic model. Methods. We conducted caecal ligation and excision surgery in cognitively presymptomatic (11-month-old) 3xTgAD mice under i.p. propofol anaesthesia. Age-matched 3xTgAD control mice received vehicle or propofol without surgery. Morris water maze testing was conducted 3 and 15 weeks later. Brains were examined with quantitative immunohistochemistry for amyloid b plaques, tau pathology, and microglial activation. Acute changes in neuroinflammatory cytokines were assessed in separate cohorts at 6 h. Results. We detected no significant differences between groups in escape latencies at either 3 or 15 weeks, but detected a significant effect of surgery in the probe test at both 3 and 15 weeks. Spatial working memory was unaffected at 16 weeks in any group. No effects of either propofol alone or propofol with surgery were detected on plaque formation, tau aggregates, or neuroinflammation. Acute biochemical assays detected no effects in brain interleukin-10 or interleukin-6 concentrations. Conclusions. Surgery in a vulnerable transgenic mouse under propofol anaesthesia was associated with minimal to no changes in short-and long-term behaviour and no changes in neuropathology. This suggests that propofol anaesthesia is associated with better cognitive outcomes in the aged, vulnerable brain compared with inhalation anaesthesia.
Elderly patients frequently report cognitive decline after surgery, a complaint known as postoperative cognitive dysfunction (POCD), a label that is currently undergoing re-evaluation. 1 Thus, interest in the relationship between anaesthetics, surgery, postoperative dementia, and Alzheimer's disease has increased. Certain anaesthetics alone increase the production 2 and aggregation 3 4 of amyloid b protein and detach and aggregate tau. [5] [6] [7] Moreover, in Alzheimer mouse models, exposure to volatile anaesthetics produces an acceleration of both amyloidopathy 8 9 and tauopathy. 10 However, only transient cognitive dysfunction follows volatile anaesthetic exposures in both older wild-type mice 8 and rats, 11 12 and cognitive effects were undetected 3 months after anaesthesia alone in even the triple transgenic Alzheimer mouse model (3xTgAD). 10 Anaesthesia is typically accompanied by surgery, and surgery can have independent effects on inflammation and cognition. Cognitive dysfunction occurs after tibial surgery in youngadult wild-type mice, resolving by 7 days, and in aged rats with a minor procedure up to 3 weeks after surgery. 13 14 However, cognitive impairment up to at least 3 months after abdominal surgery under desflurane anaesthesia was reported in the 3xTgAD mouse model. 15 Propofol, a common i.v. general anaesthetic, is known to have anti-inflammatory properties. We hypothesized that the neuroinflammation associated with surgery, leading to accelerated Alzheimer's neuropathology and symptoms, is reduced by propofol compared with volatile anaesthesia. We test this hypothesis in the setting of a vulnerable brain: the 3xTgAD mouse model.
Methods

Animals
The University of Pennsylvania institutional animal care and use committee approved the protocol; mice were treated in accordance with American Physiological Society and National Institutes of Health guidelines, and the ARRIVE (Animal Research: Reporting of In Vivo Experiments) Guidelines 16 were followed for animal reporting. Mice were bred and housed in a University of Pennsylvania Animal facility under a 12 h-12 h light-dark cycle, with room temperature and humidity constantly maintained, and all cages contained nestlets. Homozygous 3xTgAD mice, 17 harbouring the PS1M146V, APPSwe, and tau P301L transgenes, were bred using initial breeding pairs courtesy of Dr Frank LaFerla at University of California Irvine, CA, USA. Genotype was verified from tail biopsies by standard approaches. Microchips (BioMedic Data Systems, Inc., Seaford, DE, USA) were implanted s.c. at 3 weeks of age for identification and to blind the experimenter. The age range was 9-14 months (11 months mean age) at the time of anaesthesia and surgery. At this age, 3xTgAD mice have underlying progressive Alzheimer's neuropathology, but are cognitively presymptomatic, which mimics older surgical patients. The study was designed to determine whether surgery and anaesthesia accelerate the onset of underlying disease markers and result in long-term cognitive dysfunction. Male and female 3xTgAD mice were randomly divided into three experimental conditions as outlined below. Sample sizes were chosen based on our previous study 15 and others, 18 19 where statistically significant effects in 11-month-old 3xTgAD mice have been detected with the Morris water maze (MWM) using six to 12 animals per group. A total of 55 3xTgAD mice were used in this study. Wild-type controls were not repeated because no surgical effect was found in our previous study. 15 
Control and anaesthesia-alone groups
Vehicle control group Fourteen control mice were injected with 10% Liposyn II (Hospira, Lake Forest, IL, USA) at 12.5 ml kg À1 and returned to their home cage. For the acute biochemical assays n¼5, and for the first behavioural time point n¼9. One control mouse died during behavioural testing; thus n¼8 controls for behavioural studies.
Anaesthesia-alone group
Pilot studies determined that emulsified propofol 250 mg kg À1 i.p. provided 20-30 min of surgical anaesthesia. We solubilized neat propofol at 20 mg ml À1 into 10% Liposyn II (Hospira) rather than using commercial material. Twenty mice were given one injection of propofol (250 mg kg À1 ), placed in a heated and humidified chamber flushed continuously with 30% oxygen (balance nitrogen), and continuously observed for breathing, heart rate, and skin colour. Three of 20 mice died immediately after propofol injection i.p., probably as a result of vascular injection. Thus, n¼5 for the acute biochemical studies and n¼12 for the anaesthesia-only behavioural studies.
Surgery and anaesthesia group
Anaesthesia was induced as in control animals, but the mice were given 30% oxygen (balanced with nitrogen) via nose cone for surgery. The caecal ligation and excision (not puncture) was performed in aseptic conditions by the same technician, as previously reported. 15 . On completion of surgery, animals were placed in a warmed container and observed for several hours before returning to their home cage. Mice in the acute group were killed 6 h after anaesthesia or anaesthesia with surgery. Twenty-one mice were included in the surgery group; two mice died immediately after propofol i.p., one was euthanized 24 h after surgery, one was killed before the first MWM session, and two died between MWM sessions. Final groups were n¼5 for the acute cytokine studies, n¼12 for the first MWM testing, and n¼10 for the second MWM session.
Editor's key points
• Surgery and anaesthesia have been implicated in producing postoperative cognitive dysfunction in the vulnerable brain.
• Propofol alone or propofol with surgery had minimal effects on cognitive function and neuropathological markers in a mouse model of Alzheimer's disease.
• Given previous data that show impaired cognitive function after surgery and inhalation anaesthesia, these findings suggest that surgery with propofol results in better cognitive outcomes in the vulnerable brain.
Behavioural testing
Morris water maze testing was conducted as described previously and by the same technician. 15 At both time points, mice were trained for 5 days, followed by 5 days of testing, including reference memory and a probe test on the last day. At the second time point, spatial working memory testing was also conducted for 10 days. The water in the 1.5-m-diameter pool was opacified with titanium oxide and temperature maintained at 23-26 C. After trials, animals were placed in heated cages before returning to their home cage, with 45 min between trials. The MWM swim speeds were supplemented with Rotarod testing. 15 Mice were given one 60 s training trial on a non-accelerating rod at 9 rpm, followed by three test trials on an accelerating rod (4-18 rpm) for a maximum of 120 s; the duration and mean time on the rod were recorded for each animal.
Euthanasia
Mice were killed at either 6 h (cytokine studies) or after all behavioural testing at $18 weeks after anaesthesia or anaesthesia with surgery. Deep desflurane anaesthesia (9% v/v) allowed a rapid thoracotomy and left intracardiac perfusion with ice-cold phosphate-buffered saline with simultaneous exsanguination from the right atrium. For the 6 h euthanasia group, the brain was excised and the hippocampus dissected from both hemispheres, immersed in liquid nitrogen, and stored at À80 C. For the behavioural group, half of the brain was immersed in 4% paraformaldehyde for subsequent paraffin embedding and the other half immersed in liquid nitrogen and stored at À80 C.
Immunohistochemistry
Immunohistochemistry was conducted as previously described. 10 15 Briefly, brain sections were incubated overnight in mouse primary antibodies: AT8 (phosphorylated tau, MN1020; Thermo Fisher Scientific, Waltham, MA, USA), 6E10 (amyloid b, SIG-39320-200; Sigma-Aldrich, St Louis, MO, USA), or Iba-1 (ab5076; Abcam, Cambridge, MA, USA) diluted 1:1000 in Mouse on Mouse diluent (PK-2200; Vector Labs, Burlingame, CA, USA). Primary antibody was omitted from technical controls. Sections were then incubated in biotinylated secondary antibodies and avidin-biotin complex (PK-2200; Vector Labs) and diaminiobenzidine (SK4100; Vector Labs). Slides were examined by an investigator blinded to experimental conditions and images quantified using ImageJ software (www.imagej.net) last accessed 30 Nov 2016.
Biochemical enzyme-linked immunosorbent assays
Enzyme-linked immunosorbent assays (ELISAs) were conducted on frozen brain samples (left and right hippocampus pooled for each animal) obtained 6 h postanaesthesia, as previously described. 15 The antigen concentration was determined in picograms per millilitre by the ELISA and converted to picograms per milligram of wet brain tissue. 
Statistical analyses
Results
Behavioural testing
Spatial reference memory At 3 weeks after either propofol exposure or propofol and surgery (Fig. 1A) , all mice were able to locate the hidden platform throughout the 5 days of testing. No significant interaction was found (P¼0.1172), and statistical differences between the propofol group or the propofol and surgery group and the control group on each trial day were not detected (Supplementary Table  1 , post hoc P-values, CIs). Reference memory testing of the same animals at 15 weeks (Fig. 1B) showed that the animals had less difficulty in finding the hidden platform on day 1 than at 3 weeks and continued to learn throughout the 5 days of testing. Again, no interaction was found (P¼0.5794), and no differences were observed between groups (Supplementary Table 1) . Furthermore, no differences were detected for the path length measured during the spatial reference memory testing trials at 3 (P¼0.3284) or 15 weeks (P¼0.1100; Supplementary Fig. 1A and B), which correlated well with escape latencies.
Probe test
On day 5 of spatial reference memory testing, after the last trial, a probe test was conducted and the time spent in each quadrant recorded. At 3 weeks, a significant interaction (P¼0.0088) was detected, and post hoc tests showed that the surgery and propofol group spent less time in the target quadrant compared with the control group (P¼0.0058, 95% CI 5.313-36.46; Fig. 1C ). There was no difference for the propofol-only group compared with the control group (P¼0.2558, 95% CI À5.282 to 25.86). This memory impairment persisted; at 15 weeks, a significant interaction (P¼0.0059) was found, and the propofol and surgery group spent less time in the target quadrant (P¼0.0052, 95% CI 4.994-32.95) compared with the control group (Fig. 1D ). There was no difference between the control and propofol-only groups at this age (P¼0.9559, 95% CI À11.78 to 14.93). All quadrant analyses are shown in Supplementary Table 2 .
Spatial working memory test
This test is more challenging and requires animals to reach criterion three times in a row at each different hidden submerged platform location. At 16 weeks, we found no difference between groups (P¼0.3044) and no differences in the propofol (P>0.9999) or surgical groups (P¼0.2716; Fig. 1E ). (Fig. 1G) . Supplementary Fig. 1A and B. ) When the hidden submerged platform was removed for the probe test, the propofol and surgery group spent significantly less time in the target quadrant than the control mice (*P<0.01) at both 3 weeks (C) and 15 weeks (D) using a two-way ANOVA with Sidak's multiple comparisons test (Tar, Target; Adj L, adjacent left; Opp, opposite; Adj R, adjacent right).
Motor skills testing
Immunohistochemistry and biochemistry
Amyloid b Coronal brain sections were examined for evidence of extracellular amyloid b plaques, which were found only in the subiculum and hippocampal CA1 region. Plaques were quantified with immunohistochemistry at 18 weeks after the $11-month-old 3xTgAD mice had been exposed to propofol or propofol with surgery and behavioural testing (Fig. 2) . No significant difference in amyloid b plaques per square millimetre (P¼0.6370) or between the propofol (P > 0.9999) or propofol with surgery (P¼0.6435) group and the control group were found (Fig. 3A) . Plaque size was also measured, and again no significant differences were detected (Fig. 3B) .
Phosphorylated tau
Intracellular phosphorylated tau aggregates were quantified with AT8 immunohistochemistry in the subiculum and hippocampal CA1 regions at 18 weeks (Fig. 4) . The number of AT8-positive cells per square millimetre revealed no interaction (P¼0.3416) and no differences between the propofol (P¼0.3146) or propofol with surgery (P¼0.5158) group compared with the control group (Fig. 3C ).
Activated microglia
Neuroinflammation was quantified by the presence of activated microglia in the hippocampal CA1 region (Fig. 5) . No interaction was found in the number of Iba-1-positive cells per square millimetre (P¼0.1646) and no differences between the propofol-alone (P¼0.5777) or the propofol with surgery (P¼0.1125) group and the control group (Fig. 3D ).
Brain cytokines
Acute neuroinflammation was examined in a subset of mice killed at 6 h. Hippocampal interleukin (IL)-6 and IL-10 were quantified with ELISAs (Fig. 6 ). No differences were found for IL-10 (P¼0.2839) or IL-6 (P¼0.2938), and no differences were detected with post hoc tests between the propofol or propofol with surgery group compared with the control group for either IL-10 (P¼0.4587 and P¼0.2396, respectively; Fig. 6A ) or IL-6 (P¼0.4062 and P¼0.2751, respectively; Fig. 6B ).
Discussion
We found that a combination of propofol anaesthesia and a modest, sterile abdominal operation produced minimal changes in cognition and no changes in neuropathological markers of Alzheimer's disease in a cognitively presymptomatic but vulnerable mouse model. This finding is in contrast to reports in which surgery and anaesthesia in similar vulnerable animals (aged, transgenic) accelerated cognitive deficits. 14 15 20-23 In the majority of studies, the anaesthetic used was an inhalation anaesthetic, usually isoflurane. In fact, our own previous work in aged Alzheimer transgenic mice, with desflurane for the surgery, produced striking long-term effects on several measures of cognition and neuropathology. 15 This previous study used similar numbers of animals from the same colony, and all measurements were performed by the same technicians and trainees, making the results comparable. In the previous study, the desflurane-only group experienced only transient cognitive decrements, but the addition of surgery produced significant cognitive and neuropathological changes up to at least 3 months later. Those data suggested a minimal contribution by
There was no significant difference for the propofol-only group. (E) Spatial working memory testing was conducted during 10 days beginning at 16 weeks. The mean number of trials it took for each animal to reach criterion per platform was calculated; no difference was detected between the experimental groups and the control group using the Kruskal-Wallis ANOVA test of means for non-parametric data with Dunn's multiple comparisons tests. (F) The swim speed was measured for all animals at each time point during the 60 s probe test; no significant differences in swim speeds were detected using a two-way ANOVA with Sidak's multiple comparisons test. (G) Motor ability was also tested with the rotarod, and no significant differences in motor skill were detected between groups using a two-way ANOVA with Sidak's multiple comparisons test. Data are expressed as means (95% confidence intervals). Animal numbers are as follows: at 3 weeks, n¼12
for each group; at 15 weeks, n¼8 control, n¼12 propofol, and n¼10 propofol and surgery. the anaesthetic, but these new results suggest that propofol can partly mitigate the surgical effect. Our data further suggest that the underlying mechanism for propofol mitigation is a reduction in the inflammatory response. We and others have previously detected an increase in activated microglia after surgery with inhalation anaesthetic, and increases in brain IL-6, tumour necrosis factor-a, and IL-1b. 13 15 24 We hypothesized that the surgery-provoked peripheral inflammation is transduced to the brain via either vagal afferents or cytokines, thereby activating microglia. In wild-type mice, this causes only transient decrements in cognition, whereas in 3xTgAD mice this is superimposed on chronic neuropathology, thereby causing a persistent cognitive decline. Our inability to detect brain inflammation 6 h after surgery suggests mitigation by propofol. The precise mechanism for this is unclear, but could involve upstream radical scavenging 25 or a direct cellular effect on cytokine responsiveness or secretion, or both. For example, propofol completely ablated lipopolysaccharide-stimulated cytokine secretion in cultured microglial cells, compared with volatile anaesthetics. 26 Other preclinical studies using propofol to mitigate postanaesthetic, 27 28 postoperative, 14 or ageing-related cognitive changes 29 have been inconsistent, perhaps because of different animal models, exposures, or pre-existing vulnerabilities. Our results are generally consistent with the clinical literature, although results have varied. For example, a study comparing propofol with spinal anaesthesia for lithotripsy in older adults could not detect a difference attributable to the anaesthetic, but did note that the surgical procedure contributed more to POCD than the anaesthetics. 30 In contrast, a prospective randomized parallel-group study comparing propofol, sevoflurane, and epidural anaesthesia found that the sevoflurane group had a greater progression to amnestic mild cognitive impairment at 2 yr. 31 Likewise, elderly patients receiving sevoflurane for rectal surgery had a significantly higher severity of POCD compared with propofol. 32 In a small study of patients having endoscopic sinus surgery including lumbar drains, postoperative cerebrospinal fluid IL-6 was higher in the group that received sevoflurane compared with propofol and remifentanil. 33 Furthermore, reduced gene expression of pro-inflammatory cytokines was found with propofol anaesthesia in humans, 34 and in a recent study of 90 patients undergoing major non-cardiac surgery, sevoflurane was associated with greater POCD and inflammation (IL-6 and tumour necrosis factor-a) than propofol. 35 These preclinical and clinical results reinforce the idea that cognitive decline after surgery might be modulated by anaesthetic management. Translation remains tentative, however, as propofol is used rarely as a sole drug for major surgery; it is usually combined with an opioid for total i.v. anaesthesia. The influence of opioids on neuroinflammation or cognitive decline has received little attention, but some adjunctive drugs have been examined. For example, statins have been shown in preclinical studies to reduce postoperative neuroinflammation and provide neurocognitive protection, 36 although the efficacy of preoperative statin therapy is controversial in humans. 37 38 Other antiinflammatory drugs, such as dexamethasone, have failed to reduce postoperative cognitive changes. It remains unclear how effective a single, early dose of dexamethasone is at modulating neuroinflammation hours to days later, but it seems unlikely that total i.v. anaesthesia would be much superior. Thus, mechanisms other than neuroinflammation might be involved. Ultimately, the precise mechanism might be difficult to determine because propofol, like many general anaesthetics, is a promiscuous drug, having hundreds of molecular targets. 39 Potential targets mediating a protective effect could include several mitochondrial proteins, leucocyte integrins, 40 and sirtuin deacetylases. 41 The mortality associated with the present study is higher than observed in the clinical application of propofol for surgery. There are at least two causes of mortality here. Firstly, deaths immediately after propofol injections i.p. were likely to be attributable to vascular injection. Secondly, these were elderly mice with known diseaseassociated genes, making them frail and vulnerable to the stress of surgery and to the abnormal acute physiology produced by the anaesthetic. Furthermore, these changes in physiology (hypotension, hypoxaemia, hypercarbia, and hypothermia), although normally accounted for and corrected in clinical situations, are difficult to monitor or mitigate in a mouse. Although such changes and stressors could be invoked to explain the long-term cognitive effects in our previous study using desflurane, the fact that they have also occurred in the present study and were not accompanied by longterm cognitive effects suggests that their impact is small.
The animal model used in the present study was developed for the study of Alzheimer's disease. The three transgenes have been associated with early-onset or familial Alzheimer's disease, in contrast to the much more common late-onset or sporadic Alzheimer's disease. Nevertheless, the model recapitulates many of the features associated with late-onset disease, including age-related amyloidopathy, tauopathy, and cognitive decline. In the context used here, the model should be viewed as one of general smouldering neuroinflammation, a condition undoubtedly present in many otherwise asymptomatic elderly patients presenting for surgery.
In summary, an abdominal surgical procedure, conducted under propofol anaesthesia, produced minimal to no evidence of neuroinflammation or of cognitive consequence, in aged presympotmatic 3xTgAD mice, up to 4 months after the procedure. Compared with similar studies using inhalation anaesthetics, this suggests that propofol dampened the surgery-induced neuroinflammation and therefore the behavioural consequences. Such differences imply that anaesthetic management might modulate the long-term outcome after surgery in elderly patients with cognitive risk factors. 
